Ascendis Pharma A/S (NASDAQ:ASND) discussed plans to launch its newly approved achondroplasia therapy YUVIWEL during a ...

In a joint guidance document issued by the European Society for Paediatric Endocrinology and European Society of ...

Few topics provoke as much concern as the perception that puberty is beginning earlier than ever. While synthetic ...

The researchers say headphones present a plausible exposure pathway because they press against the skin for hours at a time.